Come up with a name for your new list and we'll add to it:
ViraCyte raised a round of funding on August 21, 2017. Investors include
Cancer Prevention and Research Institute of Texas.
ViraCyte provides products that restore natural immunity against life threatening viruses in patients with severely weakened immune systems, such as adults and children who have recently undergone a h…